16 December 2015 ORYZON Files Clinical Trial Application in Spain for Phase I Study with ORY-2001 for Alzheimer’s Disease
10 November 2015 Oryzon Genomics Announces First Patient Dosed in Phase I Extension Cohort of ORY-1001
4 November 2015 ORYZON Announces the Appointment of Mr. Antonio Fornieles, Ms. Isabel Aguilera and Mr. Ramon Adell as Independent Directors
24 August 2015 ORYZON to Present at the 15ª Annual Biotech in Europe Forum for Global Partnering & Investment in Basel, Switzerland